A momentous occasion for the Mariana Oncology team as they are acquired by Novartis for $1B upfront to advance precision radiopharmaceuticals to treat cancer.
Mariana Oncology today announced the company will be acquired by Novartis for up to $1.75B. Together, we will accelerate the development and delivery of precision radioligand therapeutics – therapies with the potential to transform the standard of care for people living with cancer. Read more about the exciting news here: https://lnkd.in/geVhN7RG
Congratulations to the team at Mariana Oncology!
Head of AbbVie Ventures
3moTerrific news. Congratulations, Simon Read and Team Mariana Oncology. Onwards and upwards, Team Atlas Venture!